Why 40 Is New 60 Metabolism
There is a phrase circulating in health discussions right now: “40 is the new 60” for Indian metabolism. It is a striking line. It is also a social media shorthand, not a
Obesity Rates Double in England Since 1993 as 14M Adults Now Classified Obese
A Public Health Failure Three Decades in the Making If England’s obesity rates were still the same as 1993, there would be seven million fewer adults living with obesity. Instead, there are now 14 million adults classified as obese, despite
Obesity Overtakes Underweight As Leading Child Malnutrition Form: 188 Million Worldwide At Risk
For the first time in history, obesity has overtaken underweight as the most common form of malnutrition among school-age children and adolescents worldwide, according
New Oral Diabetes Therapy Mimics Exercise Effects: Treats Type 2 Diabetes While Preventing the 30% Muscle Loss Common in Weight Treatments
A groundbreaking oral medication that treats diabetes and obesity while preserving vital muscle mass has successfully completed early clinical trials. The drug, called ATR-258,
Pfizer Oral GLP-1 Danuglipron Dropped After 73% Nausea and One Liver Injury Case Among 1,400 Patients
Pfizer has pulled the plug on danuglipron (PF-06882961), its experimental once-daily oral GLP-1 receptor agonist for weight management, after a participant in an early-stage dose-optimization trial developed potential drug-induced liver injury (DILI).
Tejal Somvanshi
India’s Obesity Crisis: 440 Million Affected by 2050
India faces a severe health challenge as obesity rates climb at an alarming pace. Recent studies published in The Lancet project that by 2050, approximately 440 million Indians could be overweight or
Semaglutide Reduces Alcohol and Smoking Cravings, Study Finds
With better health facilities, the longevity of human life is extended in modern times. But there is a problem of obesity or fatness due to the intake of more carbohydrates. Also, there
FDA Ends Tirzepatide Shortage, Orders Compounded Versions Phased Out by March 2024
The Food and Drug Administration (FDA) confirmed Thursday that Eli Lilly’s tirzepatide-based medications, Zepbound and Mounjaro, are no longer in shortage. This decision requires compounding pharmacies to cease production of alternative versions
Ozempic Weight-Loss Craze Hits India’s Gray Market: A Global Obesity Drug Sparks Serious Health Risk Concerns as Celebs Drive Demand
Ozempic, the diabetes medication turned weight-loss sensation, has taken India by storm despite its official unavailability in the country. The semaglutide-based injection, known for its appetite-suppressing effects, has gained immense popularity among
Ozempic-Linked Drug Semaglutide Trial Shows 52% Drop in Kidney Disease Markers – Is This the Next Big Breakthrough for CKD Patients?
Recent research shows that semaglutide (Ozempic®) can help patients with chronic kidney disease (CKD) and obesity, expanding its known benefits beyond diabetes treatment. The study, published in Nature Medicine, demonstrates substantial improvements
US Millennials and Gen X Face a Surge in Cancer Risk with 17 Types Showing Significant Increases, Study Reveals Alarming Trend
The sudden surge of cancer cases in the USA has led to an unsettling discovery. A new study by the American Cancer Society has revealed how US individuals from Generation X and
Karmactive Team
Smeeti Bhanu